These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3485467)

  • 1. The effect of phototherapies on cutaneous lesions of histiocytosis X in the elderly.
    Iwatsuki K; Tsugiki M; Yoshizawa N; Takigawa M; Yamada M; Shamoto M
    Cancer; 1986 May; 57(10):1931-6. PubMed ID: 3485467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histiocytosis X in an elderly patient. Ultrastructure and immunocytochemistry after PUVA photochemotherapy.
    Neumann C; Kolde G; Bonsmann G
    Br J Dermatol; 1988 Sep; 119(3):385-91. PubMed ID: 3263143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous Langerhans cell histiocytosis treated with photochemotherapy.
    Kwon OS; Cho KH; Song KY
    J Dermatol; 1997 Jan; 24(1):54-6. PubMed ID: 9046743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical characterization of pulmonary histiocytosis X cells in lung biopsies.
    Soler P; Chollet S; Jacque C; Fukuda Y; Ferrans VJ; Basset F
    Am J Pathol; 1985 Mar; 118(3):439-51. PubMed ID: 3872076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histiocytosis X cells in eosinophilic granuloma express Ia and T6 antigens.
    Schuler G; Stingl G; Aberer W; Stingl-Gazze LA; Hönigsmann H; Wolff K
    J Invest Dermatol; 1983 May; 80(5):405-9. PubMed ID: 6601681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histiocytosis X arising in Hodgkin's disease: immunophenotypic characterization with a panel of monoclonal antibodies.
    Coli A; Bigotti G; Ferrone S
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):369-73. PubMed ID: 1708928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Langerhans' cells in patients with psoriasis: effect of treatment with PUVA, PUVA bath, etretinate and anthralin.
    Czernielewski J; Juhlin L; Shroot S; Brun P
    Acta Derm Venereol; 1985; 65(2):97-101. PubMed ID: 2408430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon gamma is a marker for histiocytosis X cells in the skin.
    Neumann C; Schaumburg-Lever G; Döpfer R; Kolde G
    J Invest Dermatol; 1988 Sep; 91(3):280-2. PubMed ID: 3137270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual case of adult disseminated cutaneous Langerhans cell histiocytosis.
    Moravvej H; Yousefi M; Barikbin B
    Dermatol Online J; 2006 Oct; 12(6):13. PubMed ID: 17083893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanisms of action of phototherapy in the treatment of the most common dermatoses.
    Bulat V; Situm M; Dediol I; Ljubicić I; Bradić L
    Coll Antropol; 2011 Sep; 35 Suppl 2():147-51. PubMed ID: 22220423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous infiltrates of histiocytosis X contain plasminogen activator-bearing epidermotropic dendritic cells different from Langerhans cells.
    Burg G; Stünkel KG; Bieber T; Opitz U; Kaudewitz P
    Arch Dermatol Res; 1987; 279 Suppl():S88-91. PubMed ID: 3116952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of physicochemical agents on murine epidermal Langerhans cells and Thy-1-positive dendritic epidermal cells.
    Aberer W; Romani N; Elbe A; Stingl G
    J Immunol; 1986 Feb; 136(4):1210-6. PubMed ID: 2868057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface phenotype of Langerhans cells and lymphocytes in granulomatous lesions from patients with pulmonary histiocytosis X.
    Tazi A; Bonay M; Grandsaigne M; Battesti JP; Hance AJ; Soler P
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1531-6. PubMed ID: 8503566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of CD1 expression on surfaces of cells in bronchoalveolar fluid for diagnosis of histiocytosis X--our experience].
    Sledziewska J; Rogińska E; Obłakowski P; Słodkowska J; Hawryłkiewicz I; Kuś J; Pawlicka L; Pirozyński M; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 1999; 67(7-8):311-7. PubMed ID: 10647282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of correlated immunofluorescence and immunoperoxidase study of monoclonal markers in 2 adult cases of histiocytosis X].
    Dreno B; Milpied B; Mousset S; Pecquet C; Murat A; Bureau B; Litoux P; Barrière H
    Ann Dermatol Venereol; 1984; 111(1):31-6. PubMed ID: 6375521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New and established indications for phototherapy with narrowband UVB].
    Berneburg M; Brod C; Benedix F; Röcken M
    J Dtsch Dermatol Ges; 2005 Nov; 3(11):874-82. PubMed ID: 16232274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the methods of treatment of histiocytosis X in children in relation to its clinical picture].
    Perek D
    Probl Med Wieku Rozwoj; 1979; 8():185-219. PubMed ID: 318111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of cutaneous lesions of histiocytosis X by intralesional injections of interferon beta.
    Matsushima Y; Baba T
    Int J Dermatol; 1991 May; 30(5):373-4. PubMed ID: 2066198
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of cutaneous Langerhans' cell histiocytosis with targeted narrowband ultraviolet B phototherapy in an infant.
    Do JE; Lee JY; Kim YC
    Clin Exp Dermatol; 2009 Oct; 34(7):e280-1. PubMed ID: 19438560
    [No Abstract]   [Full Text] [Related]  

  • 20. PUVA combination therapy.
    Morison WL
    Photodermatol; 1985 Aug; 2(4):229-36. PubMed ID: 3903677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.